These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28794631)

  • 1. Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL.
    Chen N; Rong M; Shao X; Zhang H; Liu S; Dong B; Xue W; Wang T; Li T; Pan J
    Int J Nanomedicine; 2017; 12():5399-5407. PubMed ID: 28794631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
    Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
    Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining SERS analysis of serum with PSA levels for improving the detection of prostate cancer.
    Stefancu A; Moisoiu V; Couti R; Andras I; Rahota R; Crisan D; Pavel IE; Socaciu C; Leopold N; Crisan N
    Nanomedicine (Lond); 2018 Oct; 13(19):2455-2467. PubMed ID: 30284481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-enhanced Raman spectroscopy of urine for prostate cancer detection: a preliminary study.
    Del Mistro G; Cervo S; Mansutti E; Spizzo R; Colombatti A; Belmonte P; Zucconelli R; Steffan A; Sergo V; Bonifacio A
    Anal Bioanal Chem; 2015 May; 407(12):3271-5. PubMed ID: 25791298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of expressed prostatic secretion and serum using surface-enhanced Raman spectroscopy for the noninvasive detection of prostate cancer, a preliminary study.
    Shao X; Pan J; Wang Y; Zhu Y; Xu F; Shangguan X; Dong B; Sha J; Chen N; Chen Z; Wang T; Liu S; Xue W
    Nanomedicine; 2017 Apr; 13(3):1051-1059. PubMed ID: 27979746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-enhanced Raman spectroscopy of preoperative serum samples predicts Gleason grade group upgrade in biopsy Gleason grade group 1 prostate cancer.
    Qian H; Shao X; Zhu Y; Fan L; Zhang H; Dong B; Wang Y; Xu F; Zhen W; Kang X; Chen N; Liu S; Pan J; Xue W
    Urol Oncol; 2020 Jun; 38(6):601.e1-601.e9. PubMed ID: 32241690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.
    Pan J; Shao X; Zhu Y; Dong B; Wang Y; Kang X; Chen N; Chen Z; Liu S; Xue W
    Int J Nanomedicine; 2019; 14():431-440. PubMed ID: 30666105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma.
    Tan Y; Yan B; Xue L; Li Y; Luo X; Ji P
    Lipids Health Dis; 2017 Apr; 16(1):73. PubMed ID: 28388900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of prostate cancer by Raman spectroscopy: A multivariate study on patients with normal and altered PSA values.
    Correia NA; Batista LTA; Nascimento RJM; Cangussú MCT; Crugeira PJL; Soares LGP; Silveira L; Pinheiro ALB
    J Photochem Photobiol B; 2020 Mar; 204():111801. PubMed ID: 31978674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Label-free serum detection of Trichinella spiralis using surface-enhanced Raman spectroscopy combined with multivariate analysis.
    Li J; Ding J; Liu X; Tang B; Bai X; Wang Y; Li S; Wang X
    Acta Trop; 2020 Mar; 203():105314. PubMed ID: 31866336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a high throughput (HT) Raman spectroscopy method for rapid screening of liquid blood plasma from prostate cancer patients.
    Medipally DK; Maguire A; Bryant J; Armstrong J; Dunne M; Finn M; Lyng FM; Meade AD
    Analyst; 2017 Apr; 142(8):1216-1226. PubMed ID: 28001146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer.
    Feng S; Lin D; Lin J; Li B; Huang Z; Chen G; Zhang W; Wang L; Pan J; Chen R; Zeng H
    Analyst; 2013 Jul; 138(14):3967-74. PubMed ID: 23529624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer detection based on serum sample surface enhanced Raman spectroscopy.
    Vargas-Obieta E; Martínez-Espinosa JC; Martínez-Zerega BE; Jave-Suárez LF; Aguilar-Lemarroy A; González-Solís JL
    Lasers Med Sci; 2016 Sep; 31(7):1317-24. PubMed ID: 27289243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on gastric cancer blood plasma based on surface-enhanced Raman spectroscopy combined with multivariate analysis.
    Feng S; Pan J; Wu Y; Lin D; Chen Y; Xi G; Lin J; Chen R
    Sci China Life Sci; 2011 Sep; 54(9):828-34. PubMed ID: 21809036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population.
    Amirrasouli H; Kazerouni F; Sanadizade M; Sanadizade J; Kamalian N; Jalali M; Rahbar K; Karimi K
    Urol J; 2010 Jun; 7(2):99-104. PubMed ID: 20535696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer detection by gold nanoparticle based surface-enhanced Raman spectroscopy of blood serum and statistical analysis.
    Lin D; Feng S; Pan J; Chen Y; Lin J; Chen G; Xie S; Zeng H; Chen R
    Opt Express; 2011 Jul; 19(14):13565-77. PubMed ID: 21747512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
    Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
    Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of prostate-specific antigen testing in patients with prostate disease.
    Yu HJ; Chie WC; Hsieh CH; Tsai CC; Lai MK
    J Formos Med Assoc; 1996 Oct; 95(10):782-8. PubMed ID: 8961676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.